Role of screening history in clinical meaning and optimal management of positive cervical screening results
PE Castle, WK Kinney, X Xue… - JNCI: Journal of the …, 2019 - academic.oup.com
Background Cervical cancer is caused by persistent human papillomavirus (HPV) infection.
US consensus management guidelines for a positive cervical screening result typically focus …
US consensus management guidelines for a positive cervical screening result typically focus …
Effect of several negative rounds of human papillomavirus and cytology co-testing on safety against cervical cancer: an observational cohort study
Background: Current US cervical cancer screening and management guidelines do not
consider previous screening history, because data on multiple-round human papillomavirus …
consider previous screening history, because data on multiple-round human papillomavirus …
Assessing 10-year safety of a single negative HPV test for cervical cancer screening: evidence from FOCAL-DECADE cohort
A Gottschlich, D van Niekerk, LW Smith… - … Biomarkers & Prevention, 2021 - AACR
Background: Long-term safety of a single negative human papillomavirus (HPV) test for
cervical cancer screening is unclear. The HPV FOr cerviCAL Cancer Trial (FOCAL) was a …
cervical cancer screening is unclear. The HPV FOr cerviCAL Cancer Trial (FOCAL) was a …
Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30–65 years
Objective To evaluate the adoption of HPV testing and recommended extended cervical
cancer screening intervals in clinical practice, we described yearly uptake of Pap/HPV …
cancer screening intervals in clinical practice, we described yearly uptake of Pap/HPV …
Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized …
GS Ogilvie, D van Niekerk, M Krajden, LW Smith… - Jama, 2018 - jamanetwork.com
Importance There is limited information about the relative effectiveness of cervical cancer
screening with primary human papillomavirus (HPV) testing alone compared with cytology in …
screening with primary human papillomavirus (HPV) testing alone compared with cytology in …
Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive
HA Katki, M Schiffman, PE Castle… - Journal of lower …, 2013 - journals.lww.com
Objective Current US guidelines for cotesting recommend that the large numbers of women
who test Pap-negative, but human papillomavirus (HPV)–positive, return in 1 year, and …
who test Pap-negative, but human papillomavirus (HPV)–positive, return in 1 year, and …
[HTML][HTML] Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
Objectives Human papillomavirus (HPV) testing for cervical screening has been shown to
increase the yield of precancerous disease and reduce the incidence of cervical cancer …
increase the yield of precancerous disease and reduce the incidence of cervical cancer …
The population impact of human papillomavirus/cytology cervical cotesting at 3‐year intervals: Reduced cervical cancer risk and decreased yield of precancer per …
MI Silver, M Schiffman, B Fetterman, NE Poitras… - Cancer, 2016 - Wiley Online Library
BACKGROUND The objective of cervical screening is to detect and treat precancer to
prevent cervical cancer mortality and morbidity while minimizing overtreatment of benign …
prevent cervical cancer mortality and morbidity while minimizing overtreatment of benign …
[PDF][PDF] The risk of false-positive histology according to the reason for colposcopy referral in cervical cancer screening a blind revision of all histologic lesions found in …
P Dalla Palma, PG Rossi, G Collina… - American journal of …, 2008 - academia.edu
All cervical intraepithelial neoplasia (CIN) diagnoses identified during the New
Technologies for Cervical Cancer trial (ISRCTN81678807) were blindly reviewed by 2 …
Technologies for Cervical Cancer trial (ISRCTN81678807) were blindly reviewed by 2 …
Persistent HPV infection and cervical cancer risk: is the scientific rationale for changing the screening paradigm enough?
EL Franco - Journal of the National Cancer Institute, 2010 - academic.oup.com
Western European countries have relied on the Pap test for their organized or opportunistic
cervical screening programs, which have been largely successful in reducing cervical …
cervical screening programs, which have been largely successful in reducing cervical …